|
|
| Line 1: |
Line 1: |
| − | {{dziSlide | + | {{ServiceRequestCase |
| − | |order_date=November 04, 2019 06:50:52 PM | + | |identifier=DZI19-179-Case-2 |
| − | |user=Em99 | + | |intent=order |
| − | |slide_anatomy=Show | + | |category=409073007 |
| − | |dzi_filename=DZI19-67-Case-6_1
| + | |priority=routine |
| | + | |orderDetail=case |
| | + | |locationCode=learn |
| | + | |basedOn=DZI19-179 |
| | + | |code=faculty |
| | + | |supportingInfo=Lymphocytic thyroiditis (Hashimoto thyroiditis) |
| | + | |reasonCode=42yo woman with diffuse thyroid enlargement |
| | + | |subject=public |
| | + | |performer=Wf7 |
| | + | |authoredOn=November 04, 2019 06:50:52 PM |
| | + | |requester=Em99 |
| | + | |sequence=2 |
| | }} | | }} |
| − | {{dziCase | + | {{Media |
| − | |order_date=November 04, 2019 06:50:52 PM | + | |basedOn=DZI19-179-Case-2 |
| − | |user=Em99 | + | |type=image |
| − | |dziorder=DZI19-179 | + | |view=show |
| − | |case_id=2 | + | |partOf=DZI19-179 |
| − | |publish_timestamp=Choose_date 13:00 | + | |frames=1 |
| − | |clinical_hx=42yo woman with diffuse thyroid enlargement | + | |identifier=DZI19-67-Case-6_1 |
| − | |case_diagnosis=Lymphocytic thyroiditis (Hashimoto thyroiditis) | + | |createdDateTime=November 04, 2019 06:50:52 PM |
| − | |case_notes=This specimen is hypercellular, largely composed on polymorphic lymphoid cells associated with benign thyroid follicular cells and/or oncocytic cells. Oncocytic cells are arranged in flat sheets or isolated cells. They have abundant granular cytoplasm, large nuclei, and prominent nucleoli. | + | |operator=Em99 |
| − | | + | |modality=ndpi |
| − | Lymphocytic thyroiditis encompasses a variety of conditions, including CHRONIC LYMPHOCYTIC (HASHIMOTO) THYROIDITIS, subacute lymphocytic thyroiditis (postpartum and silent thyroiditis), and focal lymphocytic (silent) thyroiditis. Lymphocytic infiltrates may also be associated with Grave's disease, nodular goiter, and IgG4-related thyroiditis.
| |
| − | | |
| − | An interpretation of lymphocytic thyroiditis DOES NOT require a minimum number of follicular or oncocytic cells for adequacy.
| |
| − | | |
| − | These lesions, become candidates for FNA when they develop nodularity or an increasing thyroid volume.
| |
| − | | |
| − | Usually associated with circulating ANTITHYROIDGLOBULING and ANTITHYROID PEROXIDASE (antimicosomal) antibodies.
| |
| | }} | | }} |
